文献速递神经肿瘤

评估循环hTERT水平在胶质瘤中的潜力:血浆水平能否作为独立的预后标志物?

Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
PubMed 文献 · J Neurooncol · 2017-07-29

研究纳入72例II-IV级弥漫性胶质瘤(星形细胞瘤)患者,采用免疫荧光-免疫组化法和酶联免疫吸附试验检测肿瘤组织与血浆hTERT表达,并与相应对照比较。血浆hTERT与肿瘤内hTERT表达正相关(r=0.2794,p=0.0175),多因素Cox回归识别血浆hTERT(p<0.0005)为预后因素,且与年龄、部位或切除范围无关(p>0.05)。

要点

  • 胶质瘤组织hTERT表达显著高于对照(p<0.0001),鉴别级别灵敏度≥80%。
  • 组织与血浆hTERT均与级别正相关(r=0.8845,p<0.0001;r=0.2834,p=0.0158)。
  • 血浆hTERT与总生存负相关(r=-0.3941,p=0.0006),为独立预后因素(p<0.0005)。

核心结论

  • 首次实验证据表明,较高血浆hTERT水平与低级别和高级别胶质瘤的总生存均相关。

研究设计与样本

  • 研究检测72例II-IV级弥漫性胶质瘤(星形细胞瘤)患者的肿瘤组织和血浆hTERT表达,并与相应对照比较,采用免疫荧光-免疫组化法和酶联免疫吸附试验。

主要发现

  • 胶质瘤组织hTERT表达与对照显著不同(p<0.0001),且可在级别内鉴别,灵敏度≥80%。
  • 组织hTERT与级别正相关(r=0.8845,p<0.0001),与总生存负相关(r=-0.6558,p<0.0001)。
  • 血浆hTERT与级别正相关(r=0.2834,p=0.0158),与总生存负相关(r=-0.3941,p=0.0006)。
  • 血浆hTERT与相应肿瘤内hTERT表达显著相关(r=0.2794,p=0.0175)。
  • 多因素Cox回归识别血浆hTERT(p<0.0005)为预后因素,且与年龄、部位或切除范围无关(p>0.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glioma is an aggressive primary Neuro-epithelial tumor with dismal prognosis, since there is a lack of molecular work-up during routine radiological monitoring of the disease. Currently, a number of potential molecular prognostic and predictive biomarkers are being characterized in line with structured diagnosis defined in World Health Organization guidelines 2016. Human-telomerase reverse-transcriptase (hTERT), a marker of proliferation and maintenance of genomic integrity has thus been investigated for its clinical relevance as an independent prognosticator in glioma. Expression of the protein in tumor tissue and in plasma of 72 diffuse glioma patients (astrocytoma) grade II-IV was determined and compared with relevant controls using immunofluorescence-immunohistochemistry and enzyme-linked immuno-sorbent assay. Appropriate statistical tests were applied to establish a correlation between on-site tumor and circulating levels of the marker and its independence of covariates. Expression of the marker in glioma tissues was significantly different from controls (p < 0.0001) and could discriminate within grades with ≥80% sensitivity. The tissue and plasma levels were positively associated with grades (r = 0.8845, p < 0.0001) and (r = 0.2834, p = 0.0158) respectively, while an inverse correlation with overall survival (r = -0.6558, p < 0.0001) and (r = -0.3941, p = 0.0006) respectively, was recorded. Plasma hTERT was significantly correlated with corresponding intra-tumor expression of hTERT (r = 0.2794, p = 0.0175). Multivariate Cox-regression identified plasma hTERT (p < 0.0005) as a prognostic factor; not associated with age, site or extent of resection (p > 0.05). This is the first experimental evidence for association of higher plasma levels of hTERT with overall survival in both low and high grade glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Gandhi P, Khare R, Garg N, et al. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker? J Neurooncol. 2017. PMID: 28756592. doi:10.1007/s11060-017-2578-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。